These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21596772)

  • 21. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
    Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
    Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson's disease patients: evidence from a model-based fMRI study.
    Schonberg T; O'Doherty JP; Joel D; Inzelberg R; Segev Y; Daw ND
    Neuroimage; 2010 Jan; 49(1):772-81. PubMed ID: 19682583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Default mode network connectivity patterns associated with visual processing at different stages of Parkinson's disease.
    Rektorova I; Krajcovicova L; Marecek R; Novakova M; Mikl M
    J Alzheimers Dis; 2014; 42 Suppl 3():S217-28. PubMed ID: 25114077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus.
    Dirkx MF; den Ouden HE; Aarts E; Timmer MH; Bloem BR; Toni I; Helmich RC
    Brain; 2017 Mar; 140(3):721-734. PubMed ID: 28073788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
    Kish SJ; Shannak K; Hornykiewicz O
    N Engl J Med; 1988 Apr; 318(14):876-80. PubMed ID: 3352672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinson's disease.
    Conte A; Modugno N; Lena F; Dispenza S; Gandolfi B; Iezzi E; Fabbrini G; Berardelli A
    Brain; 2010 Sep; 133(9):2656-63. PubMed ID: 20802206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
    Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation at dorsal and ventral electrode contacts targeted at the subthalamic nucleus has different effects on motor and emotion functions in Parkinson's disease.
    Greenhouse I; Gould S; Houser M; Hicks G; Gross J; Aron AR
    Neuropsychologia; 2011 Feb; 49(3):528-34. PubMed ID: 21184765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation between striatal regions while learning to categorize via feedback and via observation.
    Cincotta CM; Seger CA
    J Cogn Neurosci; 2007 Feb; 19(2):249-65. PubMed ID: 17280514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct effects of dopamine vs STN stimulation therapies in associative learning and retention in Parkinson disease.
    Ventre-Dominey J; Mollion H; Thobois S; Broussolle E
    Behav Brain Res; 2016 Apr; 302():131-41. PubMed ID: 26778783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional imaging of cognition in Parkinson's disease.
    Carbon M; Marié RM
    Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.